139 related articles for article (PubMed ID: 301341)
1. Chemotherapy of metastatic carcinoma of the breast. A 4-drug regimen.
Mattsson W; Gynning I; Tropé C; Astedt B
Acta Radiol Ther Phys Biol; 1977 Apr; 16(2):97-108. PubMed ID: 301341
[TBL] [Abstract][Full Text] [Related]
2. The polychemotherapeutic treatment of advanced breast cancer.
Brown I; Arthur K; Banks AJ; Bond WH; Chowdhury MS; Freeman WE; Holme GM; Jones WG; Newsholme GA; Ward HW
Clin Oncol; 1977 Jun; 3(2):183-9. PubMed ID: 872472
[No Abstract] [Full Text] [Related]
3. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
Mouridsen HT; Palshof T
Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
[No Abstract] [Full Text] [Related]
4. Phase II study of combined vincristine, adriamycin, cyclophosphamide, and methotrexate with citrovorum factor factor rescue in metastatic breast cancer.
Mattsson W; Arwidi A; von Eyben F; Lindholm CE
Cancer Treat Rep; 1977 Nov; 61(8):1527-31. PubMed ID: 303543
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
Brown I; Ward HW
Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
[No Abstract] [Full Text] [Related]
6. CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.
Kolarić K; Roth A; Vukas D; Cervek J
Cancer Chemother Pharmacol; 1984; 13(2):142-4. PubMed ID: 6380789
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR
Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy of advanced squamous carcinoma of the head and neck.
Mattsson W; Hellekant C; Andréasson L
Acta Radiol Ther Phys Biol; 1977 Oct; 16(5):385-93. PubMed ID: 304655
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy for disseminated carcinoma of the breast.
Lozada JA; Grillo-López A; Vélez-Garciá E
Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
[No Abstract] [Full Text] [Related]
10. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
De Lena M; Brambilla C; Morabito A; Bonadonna G
Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
[TBL] [Abstract][Full Text] [Related]
11. [Cytostatic therapy in metastasizing breast cancer].
Gynning I; Mattsson W
Lakartidningen; 1978 Apr; 75(15):1512-5. PubMed ID: 651418
[No Abstract] [Full Text] [Related]
12. A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy.
Bull JM; Tormey DC; Li SH; Carbone PP; Falkson G; Blom J; Perlin E; Simon R
Cancer; 1978 May; 41(5):1649-57. PubMed ID: 348293
[TBL] [Abstract][Full Text] [Related]
13. Multicentre combined chemotherapy protocol for large cell advanced non Hodgkin's lymphoma.
Dumont J; Charpy-Validire P; Mosseri V; Gabarre J; Belanger C; Turpin F; Binet JL; Dreyfus F; Fourquet A; Janvier M
Hematol Oncol; 1991; 9(4-5):197-207. PubMed ID: 1720759
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy in advanced postmenopausal mammary carcinoma. A comparison between VAC and VACM therapy.
Mattsson W; Arwidi A; von Eyben F; Lindholm CE
Acta Radiol Oncol Radiat Phys Biol; 1979; 18(5):431-44. PubMed ID: 394576
[TBL] [Abstract][Full Text] [Related]
15. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
Michlmayr G; Kratzer H; Denz H; Huber H
Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
[TBL] [Abstract][Full Text] [Related]
16. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
Mouridsen HT; Palshof T; Brahm M; Rahbek I
Ugeskr Laeger; 1977 Oct; 139(44):2632-5. PubMed ID: 929742
[No Abstract] [Full Text] [Related]
17. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
[No Abstract] [Full Text] [Related]
18. Adjuvant chemotherapy in breast cancer: back to the future.
Colleoni M; Goldhirsch A
Onkologie; 2003 Apr; 26(2):111-2. PubMed ID: 12771517
[No Abstract] [Full Text] [Related]
19. Adriamycin in combination for the treatment of breast cancer: a Southwest Oncology Group study.
Tranum B; Hoogstraten B; Kennedy A; Vaughn CB; Samal B; Thigpen T; Rivkin S; Smith F; Palmer RL; Costanzi J; Tucker WG; Wilson H; Maloney TR
Cancer; 1978 Jun; 41(6):2078-83. PubMed ID: 657081
[TBL] [Abstract][Full Text] [Related]
20. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
